# Ossium Health

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/ossium-health

- Industry: Biotechnology
- Headquarters: San Francisco, US
- Website: www.ossiumhealth.com
- Total disclosed funding: $114M
- Latest round: Series C (Jun 2, 2023)
- Investors on record: 8

## About

Founded in 2016 by Kevin Caldwell (CEO), and Erik Woods (CSO), and based in California, US, Ossium Health, Inc. operates as a bioengineering company that offers a biobank that works with healthcare providers, life science companies, and organ procurement organizations to develop and deploy cell therapies. In July Ossium Health, Inc. raised USD 52 million in Series C funding led by investor CPMG, with participation from other investors Alumni Ventures Group and Asahi Kasei Ventures. As of 2023, the company operates from offices in California and Indianapolis, US. 

The firm develops and offers a bone marrow bank that is used to develop stem cell therapies to treat blood cancers, improve organ transplantation, and repair damage from radiation. The firm also develops bone-marrow-derived stem cell therapies that could enable organ transplant recipients at scale. The company’s products include bone matrix allograft, human mesenchymal stem cells, GMP CD34+ cells, Human CD34+ cells, Hematopoietic Progenitor Cells (HPCs), and RUP mesenchymal stem cells.

## Funding rounds

- Series C, Jun 2, 2023, $52M — Vivo Capital, First Round Capital, Alumni Ventures Group, Manta Ray Ventures, Asahi Kasei Corporate Venture Capital
- Series B, Oct 30, 2020, $62M — General Catalyst Partners, Vivo Capital, First Round Capital, Gaingels, XYZ Ventures, Manta Ray Ventures

## Investors

- General Catalyst Partners (https://capitalatlas.ai/funds/general-catalyst-partners) — Series B
- Vivo Capital (https://capitalatlas.ai/funds/vivo-capital) — Series B, Series C
- First Round Capital (https://capitalatlas.ai/funds/first-round-capital) — Series B, Series C
- Gaingels (https://capitalatlas.ai/funds/gaingels) — Series B
- XYZ Ventures (https://capitalatlas.ai/funds/xyz-ventures) — Series B
- Manta Ray Ventures (https://capitalatlas.ai/funds/manta-ray-ventures) — Series B, Series C
- Alumni Ventures Group (https://capitalatlas.ai/funds/alumni-ventures-group) — Series C
- Asahi Kasei Corporate Venture Capital — Series C